SB 849 requires Tennessee medical and osteopathic boards to create an optional continuing education course on maternal mental health for healthcare professionals. It directly affects physicians specializing in obstetrics/gynecology, pediatrics, and psychiatry, as well as certain psychologists. The course must cover screening practices, types of maternal mental health disorders, evidence-based treatments, and when to consult a psychiatrist. Boards must update the curriculum periodically to reflect new research and accept course completion as credit toward required continuing education.
HB 62 authorizes Tennessee athletic trainers to use dry needling for preventing, treating, and rehabilitating athletic injuries, directly affecting licensed athletic trainers in the state. The bill requires the Board of Athletic Trainers to establish minimum competency standards that practitioners must demonstrate to safely perform dry needling. It clarifies that this practice does not constitute acupuncture under existing law. The policy change expands athletic trainers' scope of practice with specific safety safeguards, effective March 28, 2025.
SB 1261 requires Tennessee health insurance companies, including TennCare and pharmacy benefits managers, to follow strict rules when using artificial intelligence (AI) for healthcare decisions like approving treatments. It mandates that AI tools must base decisions on individual patient medical history and provider recommendations - not just group data - and cannot replace licensed doctors in determining medical necessity. Insurers must disclose AI use in their policies, regularly review AI performance, and ensure patient data is handled securely under HIPAA. The law prohibits AI from discriminating or causing harm and treats violations as unfair claims practices, allowing patients to sue for damages.
This resolution urges the U.S. Congress to require the Department of Veterans Affairs (VA) to include veterans who received certain COVID-19 treatments (administered under Emergency Use Authorization before full FDA approval) and anthrax vaccinations as qualifying exposures under the PACT Act. It directly affects veterans exposed to these treatments during service, potentially expanding their access to VA healthcare and benefits previously reserved for those with toxic exposures like burn pits. The resolution also calls for Congress to investigate the military's administration of these substances, including whether they were given without proper consent or approval. As a non-binding resolution, it does not change VA policy but advocates for legislative action to address veterans' health concerns.
SB 890 requires Tennessee health insurance companies to create two digital systems: one allowing healthcare providers to access patient electronic health records and another for processing prior authorization requests (like insurance approvals for treatments). It also shortens the timeline for certain health insurance actions by changing the requirement from 10 working days to 10 calendar days. This law directly affects health insurance entities, healthcare providers, and patients by improving access to medical records and streamlining authorization processes. The bill takes effect on July 1, 2025.
HB 1291 requires Tennessee health insurance carriers to cover mental health services at the same level as coverage for alcoholism and drug dependence. This means insurance plans must provide equal benefits, coverage, and reimbursement rates for mental health treatment compared to substance use disorder treatment. The bill also mandates that insurers include clear explanations of this equal coverage in plan materials. It applies to all health insurance plans issued or renewed on or after July 1, 2025.
HB 15 would allow Tennessee's governor to expand Medicaid eligibility exclusively for sickle cell disease treatment, in alignment with federal law. The bill requires the governor to negotiate with federal health officials (Centers for Medicare and Medicaid Services) on the specific terms of this expansion. This change would directly affect Tennessee residents diagnosed with sickle cell disease by potentially providing Medicaid coverage for their treatment. The expansion is strictly limited to sickle cell disease and must comply with the federal Patient Protection and Affordable Care Act.
SB 1369 removes the requirement for acute care hospitals in Tennessee to obtain state approval (a "certificate of need") to establish or operate, effective July 1, 2028. It defines "acute care hospital" as one primarily treating patients with an average stay of 25 days or less. This change directly affects new and existing acute care hospitals by eliminating a regulatory hurdle for expansion or operation. The bill amends specific Tennessee Code sections to implement this change, while maintaining certificate of need requirements for other hospital types.
SB 225 requires Tennessee health insurers to reimburse chiropractic physicians at the same rate as medical doctors for identical services, amending Tennessee Code Annotated Titles 56 and 63. It prohibits insurers from using separate payment codes or methodologies for chiropractic services compared to physician services, ensuring equal reimbursement based on nationally recognized coding systems like the CPT book. This applies to private health insurance plans but excludes TennCare, CoverKids, and government-provided insurance. The bill aims to eliminate reimbursement disparities for chiropractors offering equivalent services to medical doctors. It was scheduled to take effect July 1, 2025, but failed in committee on March 25, 2025.
SB 428 requires insurers offering health insurance plans to Tennessee state employees to treat non-opioid pain medications (FDA-approved for pain treatment) equally with opioids on their preferred drug list, ensuring they are not disadvantaged in coverage or discouraged. It also mandates separate reimbursement for healthcare providers and hospitals when non-opioid pain treatments are provided to covered employees. The law applies immediately upon FDA approval of a non-opioid drug and takes effect July 1, 2025. This directly affects insurers and state employee health plans under Tennessee Code.